Skip to main content
. Author manuscript; available in PMC: 2017 Jun 27.
Published in final edited form as: Adv Funct Mater. 2016 Apr 14;26(22):3916–3932. doi: 10.1002/adfm.201504178

Table 4.

Summary of magnetic liquids biocompatibility.

Magnetic liquids Concentrations pH Cell type Short-term viability Long-term proliferation References
Gd·DTPA 0, 4, 40, and 200 mm 7.2 NIH 3T3 cells/ Saccharomyces cerevisiae Survived and grew over 2 d at 40 mm/ Viability was similar at all concentrations 0-40 mm didn't inhibit the cell growth/ 40 and 200 mm inhibit cell division [31]
Gd·DTPA 39, 79 and 240 mm NA HaCaT cells 90% at 39 mm and 87% at 79 mm after 3 h, died at 240 mm NA [20]
Gd·BOPTA/Gd·DOTA/Gd·HP·DO3A 0, 10, 25, 50, 85, and 100 mm NA Jurkat cells ∼40% on 1st d at 100 mm/∼75% on 1st d at 100 mm/>90% on 1st d at all concentrations 25-100 mm inhibited the cell division/Cells proliferated normally below 25 mm/Cells proliferated almost normally at all concentrations [96]
Gd solution 0, 30, 50, and 100 mm Neutral JH-EsoAd1 cells ∼100% at all concentrations on 1st d Maintained normal proliferation rates over 5 d [43]
1 BSA coated ferrofluid 0, 15, 30, and 45 mg mL-1 NA HUVECs >95% at all concentrations up to 2 h Maintained normal proliferation rates (to confluence) [25]
1 Citrate stabilized ferrofluid 0, 20, 40, 50, 60, 80, and 100 mm 7.4 Red blood cells 75% NA [24]
1 Graft copolymer functionalized ferrofluid 0.30%, 0.79%, and 1.03% v/v 6.8 Red blood cells/ HeLa cells 100 % at all concentrations up to 2 h/ ∼90 at all concentrations up to 2 h NA [65]
2 EMG 408 ferrofluid 1.1% v/v ∼7 Escherichia coli/ Saccharomyces cerevisiae Remained almost unchanged viability over 2 d NA [30]
2 EMG 408 ferrofluid 0.3% v/v ∼7 Saccharomyces cerevisiae 10% reduction in the number of cells over 24-48 h NA [67], [71], [73]
1

Custom-made ferrofluids and

2

commercially available from Ferrotec Corporation.